Alterity Therapeutics (ATHE) Other Non-Current Liabilities (2009 - 2025)

Alterity Therapeutics' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $617156.7 for Q4 2025.

• On a quarterly basis, Other Non-Current Liabilities rose 60.79% year-over-year to $617156.7 in Q4 2025; TTM through Dec 2025 was $617156.7, a 60.79% increase from a year earlier, with the FY2025 full-year figure at $560960.6, up 60.39% from the prior year.
• Other Non-Current Liabilities improved to $617156.7 in Q4 2025 per ATHE's latest filing, from $560960.6 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $617156.7 in Q4 2025 and bottomed at $5307.0 in Q2 2024.
• The 5-year median for Other Non-Current Liabilities is $436594.4 (2021), against an average of $379120.2.
• Across the five-year window, Other Non-Current Liabilities soared 72636.73% in 2021 and sank 98.45% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $446642.3 in 2021, then gained by 2.9% to $459591.4 in 2022, then fell by 7.19% to $426546.5 in 2023, then dropped by 10.01% to $383839.2 in 2024, then surged by 60.79% to $617156.7 in 2025.
• Per Business Quant, the three latest ATHE Other Non-Current Liabilities figures stand at $617156.7 (Q4 2025), $560960.6 (Q2 2025), and $383839.2 (Q4 2024).